Menopause Matters magazine ISSUE 76 out now. (Summer issue, June 2024)
This is what the public consultation needs to be aware of before it reaches any decision. Moreover, isn't it what everyone has been asking for, that all the 'scaremongering' cancer warnings should not be mentioned in the PIL of low estradiol levels formulations? If there's no chance of cancer (or a negligible chance), why would a prescription be needed?